We are live on
!
Find out more
Rafferty Asset Management Portfolio holdings
AUM
$24.6B
1-Year Est. Return
47.06%
This Fund
S&P 500
This Quarter
Est. Return
+8.79%
1 Year Est. Return
+47.06%
3 Year Est. Return
+108.18%
5 Year Est. Return
+135.84%
10 Year Est. Return
+427.13%
AUM
$17.7B
AUM Growth
+$2.98B
(+20%)
Cap. Flow
+$1.81B
Cap. Flow
% of AUM
10.19%
Top 10 Holdings %
Top 10 Hldgs %
35.18%
Holding
1,173
New
33
Increased
727
Reduced
328
Closed
84
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$505M |
| 2 |
Intel
INTC
|
+$122M |
| 3 |
Apple
AAPL
|
+$122M |
| 4 |
Microsoft
MSFT
|
+$98.1M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$97.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$90.1M |
| 2 |
VanEck Gold Miners ETF
GDX
|
+$37.3M |
| 3 |
iShares MSCI Brazil ETF
EWZ
|
+$32.8M |
| 4 |
State Street SPDR Bloomberg High Yield Bond ETF
JNK
|
+$15.9M |
| 5 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$15.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 45.79% |
| 2 | Financials | 10.21% |
| 3 | Healthcare | 7.68% |
| 4 | Consumer Discretionary | 4.29% |
| 5 | Energy | 4.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
Popular Inc
BPOP
$11.2B
| $7.27M | 0.04% |
120,077
+45,987
| +62% | +$2.71M |
|
327
Becton Dickinson
BDX
$45.6B
| $7.26M | 0.04% |
27,515
+2,114
| +8% | +$537K |
|
328
Range Resources
RRC
$9.24B
| $7.23M | 0.04% |
245,961
-93,395
| -28% | -$2.54M |
|
329
Madrigal Pharmaceuticals
MDGL
$11.4B
| $7.22M | 0.04% |
31,256
+3,121
| +11% | +$845K |
|
330
Matador Resources
MTDR
$6B
| $7.21M | 0.04% |
137,893
-32,982
| -19% | -$1.59M |
|
331
Hartford Financial Services
HIG
$39.2B
| $7.17M | 0.04% |
99,565
-6,628
| -6% | -$465K |
|
332
CDW
CDW
$18.6B
| $7.15M | 0.04% |
38,967
+9,696
| +33% | +$1.69M |
|
333
Chord Energy
CHRD
$7.78B
| $7.12M | 0.04% |
46,278
-17,782
| -28% | -$2.58M |
|
334
CNX Resources
CNX
$4.9B
| $7.1M | 0.04% |
400,704
-167,589
| -29% | -$2.71M |
|
335
Mercado Libre
MELI
$95.6B
| $7.08M | 0.04% |
5,977
+1,639
| +38% | +$2.06M |
|
336
Zentalis Pharmaceuticals
ZNTL
$350M
| $7.08M | 0.04% |
250,957
+42,039
| +20% | +$1.01M |
|
337
Ardelyx
ARDX
$1.25B
| $7.08M | 0.04% |
2,087,124
+538,992
| +35% | +$2.21M |
|
338
Ovintiv
OVV
$17B
| $7.07M | 0.04% |
185,711
-36,716
| -17% | -$1.33M |
|
339
lululemon athletica
LULU
$13.6B
| $7.06M | 0.04% |
18,644
+967
| +5% | +$357K |
|
340
Syndax Pharmaceuticals
SNDX
$1.73B
| $7.02M | 0.04% |
335,347
+52,464
| +19% | +$1.09M |
|
341
Columbia Banking Systems
COLB
$8.84B
| $7.01M | 0.04% |
345,842
+151,105
| +78% | +$3.19M |
|
342
Southern Company
SO
$106B
| $7M | 0.04% |
99,645
+19,689
| +25% | +$1.41M |
|
343
Comstock Resources
CRK
$3.73B
| $6.99M | 0.04% |
602,180
-204,733
| -25% | -$2.13M |
|
344
Murphy Oil
MUR
$5.48B
| $6.98M | 0.04% |
182,375
-55,340
| -23% | -$2.04M |
|
345
Celldex Therapeutics
CLDX
$3.02B
| $6.97M | 0.04% |
205,508
+59,772
| +41% | +$2.01M |
|
|
PDCE
346
DELISTED
PDC Energy, Inc.
PDCE
| $6.92M | 0.04% |
97,319
-35,628
| -27% | -$2.41M |
|
347
PBF Energy
PBF
$8.65B
| $6.88M | 0.04% |
168,026
-28,783
| -15% | -$1.09M |
|
348
BioCryst Pharmaceuticals
BCRX
$2.35B
| $6.86M | 0.04% |
974,963
+154,442
| +19% | +$1.24M |
|
349
HF Sinclair
DINO
$16.7B
| $6.82M | 0.04% |
152,880
-23,996
| -14% | -$1.05M |
|
350
AstraZeneca
AZN
$266B
| $6.79M | 0.04% |
47,456
+7,750
| +20% | +$1.14M |
|
Similar funds
CS
AF
SC
JG
Rafferty Asset Management's Q2 2023 Portfolio in Review
As of Q2 2023, Rafferty Asset Management held 1,173 positions worth $17.7B, up 20% from $14.8B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Rafferty Asset Management deployed $1.81B of net new capital in Q2 2023, opening 33 new positions and adding to 727 existing holdings. Its largest new stake was Biomea Fusion: 136,903 shares worth $3.01M.
By sector, the portfolio is most concentrated in Technology at 46% of assets, up from 42% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was NVIDIA, an estimated $90.1M trimmed.
- Rafferty Asset Management's largest Q2 2023 buy was Biomea Fusion: 136,903 shares worth $3.01M.
- Rafferty Asset Management added most to iShares 20+ Year Treasury Bond ETF in Q2 2023, an estimated $505M increase.
- Rafferty Asset Management's biggest Q2 2023 reduction was NVIDIA, cutting an estimated $90.1M.
- Rafferty Asset Management fully exited Prometheus Biosciences, Inc. Common Stock in Q2 2023, selling an estimated $6.38M.
- Rafferty Asset Management's ten largest holdings make up 35% of its $17.7B portfolio in Q2 2023.
- Rafferty Asset Management opened 33 new positions and closed 84 in Q2 2023.
- Rafferty Asset Management's portfolio value rose 20% quarter-over-quarter to $17.7B.
Based on Rafferty Asset Management's 13F filing for Q2 2023, filed 11 Aug 2023.